Ubs Global Asset Management Americas »

Iteos Therapeutics shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Iteos Therapeutics (ITOS) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Iteos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iteos Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iteos Therapeutics by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2023-12-31 $474k 43k 10.95
2023-09-30 $474k 43k 10.95
2023-06-30 $342k 25k 13.61
2023-03-31 $342k 25k 13.61
2022-12-31 $413k 21k 19.53
2022-03-31 $216k 6.7k 32.18

More positions owned by Ubs Global Asset Management Americas

Microsoft Corp Equity Us Cm (MSFT)
Apple Equity Us Cm (AAPL)
Amazon Equity Us Cm (AMZN)
Nvidia Corp Equity Us Cm (NVDA)
Alphabet Inc Cl A Equity Us Cm (GOOGL)
Tesla Equity Us Cm (TSLA)
Meta Platforms Equity Us Cm (META)
Alphabet Inc Cl C Equity Us Cm (GOOG)
Unitedhealth Group Equity Us Cm (UNH)
Broadcom Equity Us Cm (AVGO)
Adobe Equity Us Cm (ADBE)
Eli Lilly &#38 Equity Us Cm (LLY)
Visa Inc Class A Shares Equity Us Cm (V)
Home Depot Equity Us Cm (HD)
Johnson &#38 Johnson Equity Us Cm (JNJ)

View all positions for Ubs Global Asset Management Americas

Top funds holding Iteos Therapeutics

RA Capital Management
BlackRock
EcoR1 Capital
Boxer Capital
Vanguard Group
BVF
Citadel Advisors
Millennium Management
Dimensional Fund Advisors
Goldman Sachs Group
Deerfield Management Company
683 Capital Management
Geode Capital Management
Jacobs Levy Equity Management
Saturn V Capital Management

View all funds holding Iteos Therapeutics